Assembly Biosciences, Inc. (ASMB) Earnings History
Annual and quarterly earnings data from 2008 to 2025
Loading earnings history...
ASMB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ASMB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 99.8% | -16.8% | -8.5% |
| 2024 | 100.0% | -159.3% | -140.9% |
| 2023 | -582.7% | -902.5% | -854.8% |
| 2022 | - | - | - |
| 2021 | 100.0% | -2121.7% | -2076.4% |
Download Data
Export ASMB earnings history in CSV or JSON format
Free sign-in required to download data
Assembly Biosciences, Inc. (ASMB) Earnings Overview
As of May 8, 2026, Assembly Biosciences, Inc. (ASMB) reported trailing twelve-month net income of -$6M, reflecting +91.8% year-over-year growth. The company earned $-0.38 per diluted share over the past four quarters, with a net profit margin of -8.5%.
Looking at the long-term picture, ASMB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2009.
Assembly Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ARWR (-$301M net income, -0.2% margin), RCKT (-$223M net income), REPL (-$315M net income), ASMB has room to improve margins relative to the peer group. Compare ASMB vs ARWR →
ASMB Earnings vs Peers
Earnings metrics vs comparable public companies
ASMB Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | +84.8% | -$12M | $-0.55 | -8.5% | -16.8% |
| 2024 | -$40M | +34.4% | -$45M | $-6.69 | -140.9% | -159.3% |
| 2023 | -$61M | +34.2% | -$65M | $-13.38 | -854.8% | -902.5% |
| 2022 | -$93M | +28.3% | -$94M | $-22.82 | - | - |
| 2021 | -$130M | -108.9% | -$133M | $-36.00 | -2076.4% | -2121.7% |
| 2020 | -$62M | +36.3% | -$65M | $-15.00 | -78.6% | -81.9% |
| 2019 | -$98M | -7.6% | -$103M | $-27.80 | -611.6% | -643.4% |
| 2018 | -$91M | -112.0% | -$93M | $-39.80 | -613.0% | -626.4% |
| 2017 | -$43M | +3.3% | -$52M | $-24.10 | -474.7% | -579.1% |
| 2016 | -$44M | -55.6% | -$45M | $-25.70 | - | - |
See ASMB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASMB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASMB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASMB — Frequently Asked Questions
Quick answers to the most common questions about buying ASMB stock.
Is ASMB growing earnings?
ASMB EPS is $-0.38, with earnings growth accelerating to +91.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-6M.
What are ASMB's profit margins?
Assembly Biosciences, Inc. net margin is -8.5%, with operating margin at -16.8%. Below-average margins reflect competitive or cost pressures.
How consistent are ASMB's earnings?
ASMB earnings data spans 2008-2025. The accelerating earnings trend is +91.8% YoY. Historical data enables comparison across business cycles.